SummaryThe aim of the present study was to assess the cytotoxicity of manumycin, a specific inhibitor of farnesyl:protein transferase, as well as its effects on protein isoprenylation and kinase-dependent signal transduction in COLO320-DM human colon adenocarcinoma which harbours a wild-type K-ras gene. Immunoblot analysis of isolated cell membranes and total cellular lysates of COLO320-DM cells demonstrated that manumycin dose-dependently reduced p21ras farnesylation with a 50% inhibitory concentration (IC 50 ) of 2.51 ± 0.11 µM and 2.68 ± 0.20 µM, respectively, while the geranylgeranylation of p21rhoA and p21rap1 was not affected. Manumycin dose-dependently inhibited (IC 50 = 2.40 ± 0.67 µM) the phosphorylation of the mitogen-activated protein kinase/extracellular-regulated kinase 2 (p42MAPK/ERK2), the main cytoplasmic effector of p21ras, as well as COLO320-DM cell growth (IC 50 = 3.58 ± 0.27 µM) without affecting the biosynthesis of cholesterol. Mevalonic acid (MVA, 100 µM), a substrate of the isoprenoid synthesis, was unable to protect COLO320-DM cells from manumycin cytotoxicity. Finally, manumycin 1-25 µM for 24-72 h induced oligonucleosomal fragmentation in a dose-and timedependent manner and MVA did not protect COLO320-DM cells from undergoing DNA cleavage. The present findings indicate that the inhibition of p21ras processing and signal transduction by manumycin is associated with marked inhibition of cell proliferation and apoptosis in colon cancer cells and the effect on cell growth does not require the presence of a mutated ras gene for maximal expression of chemotherapeutic activity.